BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics Read more
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa Read more
Ultimovacs Receives FDA Orphan Drug Designation for the UV1 Cancer Vaccine for Treatment of Mesothelioma Read more
FDA approves Novartis Cosentyx as first intravenous (IV) formulation interleukin-17A antagonist for rheumatic diseases Read more
Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts STENOVA Phase 2a Clinical Trial Read more
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline Read more
Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date Read more
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment Read more
ADVANZ PHARMA and Dimerix enter into an Exclusive License Agreement to commercialise DMX-200 in Europe, Canada, Australia, and New Zealand Read more